The effect of different preparations of hormone therapy on tumor necrosis factor-α levels in women with surgical menopause

References

• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280: 605–613
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2004; 291: 1701–1712
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Colditz G A, Willett W C, Manson J E, Rosner B, Speizer F E, Hennekens C H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325: 756–762
   PubMed Web of Science ®Google Scholar
• Rosenblum M G, Donato N J. Tumor necrosis factor α: a multifaceted peptide hormone. Crit Rev Immunol 1989; 9: 21–44
   PubMed Web of Science ®Google Scholar
• Anderson H D, Rahmutula D, Gardner D G. Tumor necrosis factor-α inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 2004; 279: 963–969
   PubMed Web of Science ®Google Scholar
• Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol 2004; 286: L37–L48
   PubMed Web of Science ®Google Scholar
• Tracey K J, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491–503
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90–119
   PubMed Web of Science ®Google Scholar
• Kamada M, Irahara M, Maegawa M, Ohmoto Y, Takeji T, Yasui T, Aono T. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 2001; 184: 309–314
   PubMed Web of Science ®Google Scholar
• Sites C K, Toth M J, Cushman M, L'Hommedieu G D, Tchernof A, Tracy R P, Poehlman E T. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002; 77: 128–135
   PubMed Web of Science ®Google Scholar
• Arenas I A, Armstrong S J, Xu Y, Davidge S T. Chronic tumor necrosis factor-α inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension 2005; 46: 76–81
   PubMed Web of Science ®Google Scholar
• Ito A, Bebo B F, Jr, Matejuk A, Zamora A, Silverman M, Fyfe-Johnson A, Offner H. Estrogen treatment down-regulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 2001; 167: 542–552
   PubMed Web of Science ®Google Scholar
• Rickard D, Russell G, Gowen M. Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporos Int 1992; 2: 94–102
   PubMed Web of Science ®Google Scholar
• Wang X, Schwartz Z, Yaffe P, Ornoy A. The expression of transforming growth factor-β and interleukin-1β mRNA and the response to 1,25(OH)2D3, 17β-estradiol, and testosterone is age dependent in primary cultures of mouse-derived osteoblasts in vitro. Endocrine 1999; 11: 13–22
   PubMedGoogle Scholar
• Ralston S H, Russell R G, Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990; 5: 983–988
   PubMed Web of Science ®Google Scholar
• Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli L V. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A 1991; 88: 5134–5138
   PubMed Web of Science ®Google Scholar
• Shanker G, Sorci-Thomas M, Adams M R. Estrogen modulates the expression of tumor necrosis factor α mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lymphokine Cytokine Res 1994; 13: 377–382
   PubMedGoogle Scholar
• Kimble R B, Srivastava S, Ross F P, Matayoshi A, Pacifici R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 1996; 271: 28890–28897
   PubMed Web of Science ®Google Scholar
• Bernard-Poenaru O, Roux C, Blanque R, Gardner C, de Vemejoul M C, Cohen-Solal M E. Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporos Int 2001; 12: 769–776
   PubMedGoogle Scholar
• Rogers A, Eastell R. The effect of 17β-estradiol on production of cytokines in cultures of peripheral blood. Bone 2001; 29: 30–34
   PubMed Web of Science ®Google Scholar
• Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen. Circulation 2002; 105: 1436–1439
   PubMed Web of Science ®Google Scholar
• Parkar M, Tabona P, Newman H, Olsen I. IL-6 expression by oral fibroblasts is regulated by androgen. Cytokine 1998; 10: 613–619
   PubMedGoogle Scholar
• Palacios S. Tibolone: what does tissue specific activity mean?. Maturitas 2001; 37: 159–165
   PubMed Web of Science ®Google Scholar
• Rifai N, Bachorik P S, Albers J J. Lipids, lipoproteins, and apolipoproteins. Tietz textbook of clinical chemistry, C A Burtis, E R Ashwood. WB Saunders Company, Philadelphia, PA 1999; 809–861
   Google Scholar
• Zegura B, Guzic-Salobir B, Sebestjen M, Keber I. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Menopause 2006; 13: 643–650
   PubMed Web of Science ®Google Scholar
• Conraads V M, Bosmans J M, Schuerwegh A J, De Clerck L S, Bridts C H, Wuyts F L, Stevens W J, Vrints C J. Association of lipoproteins with cytokines and cytokine receptors in heart failure patients. Differences between ischaemic versus idiopathic cardiomyopathy. Eur Heart J 2003; 24: 2221–2226
   PubMedGoogle Scholar
• Rauchhaus M, Koloczek V, Volk H, Kemp M, Niebauer J, Francis D P, Coats A J, Anker S D. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol 2000; 76: 125–133
   PubMed Web of Science ®Google Scholar
• Piche M E, Lemieux S, Weisnagel S J, Corneau L, Nadeau A, Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-α, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96: 92–97
   PubMed Web of Science ®Google Scholar
• Maggio M, Basaria S, Ceda G P, Ble A, Ling S M, Bandinelli S, Valenti G, Ferrucci L. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 2005; 28(Suppl)116–119
   PubMedGoogle Scholar
• Davis S R. Testosterone deficiency in women. J Reprod Med 2001; 46(Suppl 3)291–296
   PubMedGoogle Scholar
• Mathur R S, Landgreve S C, Moody L O, Semmens J P, Williamson H O. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone binding globulin in post-menopausal women. Maturitas 1985; 7: 129–133
   PubMed Web of Science ®Google Scholar
• Puder J J, Freda P U, Goland R S, Wardlaw S L. Estrogen modulates the hypothalamic–pituitary–adrenal and inflammatory cytokine responses to endotoxin in women. J Clin Endocrinol Metab 2001; 86: 2403–2408
   PubMed Web of Science ®Google Scholar